News
$67.5m Series B financing to support development of XyloCor Therapeutics’ novel cardiovascular disease gene...
Jeito Capital, an independent Private Equity fund dedicated to biopharma, is leading a $67.5 million Series B financing round in XyloCor Therapeutics, a clinical-stage...
Phillips Medisize expands inhalation drug delivery capabilities with acquisition
Molex, a parent to Phillips Medisize, has completed, through an affiliate, the acquisition of Vectura from Vectura Fertin Pharma, a subsidiary of Philip Morris...
Baird Capital invests in life sciences consultancy Newmarket Strategy
Newmarket Strategy, an independent life sciences consultancy and market access specialist, has secured a growth capital investment from Baird Capital’s Global Private Equity Fund....
